IDEAS home Printed from https://ideas.repec.org/a/abf/journl/v41y2022i4p32889-32895.html

3D Screen Printing Enables Application of Integrated QR Codes on Pharmaceutical Dosage Forms in Mass Production – A Game Changer

Author

Listed:
  • Marcel Enke

    (Laxxon Medical GmbH, Germany)

  • Klaus Kühne

    (Laxxon Medical Corp, USA
    Division of Pharmaceutical Technology, Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen, Germany)

  • Stefan Seyferth

    (Division of Pharmaceutical Technology, Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen, Germany)

  • Dagmar Fischer

    (Division of Pharmaceutical Technology, Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen, Germany)

  • Achim Schneeberger

    (Laxxon Medical Corp, USA
    Division of Pharmaceutical Technology, Department of Chemistry and Pharmacy, Friedrich-Alexander University Erlangen, Germany)

Abstract

Quick Response (QR) codes have shown enormous potential to improve the flow of information from industry to providers and patients, by enabling access to supplemental safety data, potential drug interactions, among numerous other use-cases in real-time....

Suggested Citation

  • Marcel Enke & Klaus Kühne & Stefan Seyferth & Dagmar Fischer & Achim Schneeberger, 2022. "3D Screen Printing Enables Application of Integrated QR Codes on Pharmaceutical Dosage Forms in Mass Production – A Game Changer," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 41(4), pages 32889-32895, February.
    • Handle: RePEc:abf:journl:v:41:y:2022:i:4:p:32889-32895
    DOI: 10.26717/BJSTR.2022.41.006630
    as

    Download full text from publisher

    File URL: https://biomedres.us/pdfs/BJSTR.MS.ID.006630.pdf
    Download Restriction: no
    File URL: https://biomedres.us/fulltexts/BJSTR.MS.ID.006630.php
    Download Restriction: no
    File URL: https://libkey.io/10.26717/BJSTR.2022.41.006630?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Carrie E. Pierce & Sieta T. Vries & Stephanie Bodin-Parssinen & Linda Härmark & Phil Tregunno & David J. Lewis & Simon Maskell & Raphael Eemeren & Alicia Ptaszynska-Neophytou & Victoria Newbould & Nab, 2019. "Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR," Drug Safety, Springer, vol. 42(4), pages 477-489, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Eyob Alemayehu Gebreyohannes & Christopher Thornton & Myra Thiessen & Sieta T. Vries & Gretchen Coombs & Indae Hwang & Renly Lim, 2025. "Views on the Development and Use of a New Digital Adverse Drug Event Reporting Platform in Australia: A Qualitative Study," Drug Safety, Springer, vol. 48(2), pages 179-190, February.
    2. Katherine Chinchilla & Cristiano Matos & Victoria Hall & Florence Hunsel, 2021. "Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation," Drug Safety, Springer, vol. 44(2), pages 181-191, February.
    3. Joanne Barnes & Jane L. Sheridan & Christine Yang Dong & Linda Härmark & Sunita Vohra & Mira Harrison-Woolrych, 2020. "Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand," Drug Safety, Springer, vol. 43(10), pages 981-998, October.
    4. Babafunso Aderemi Adenuga & Timothy William Rennie, 2019. "A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia," Drug Safety, Springer, vol. 42(7), pages 915-917, July.
    5. Christine Mary Hallinan & Yvonne Ann Bonomo, 2022. "The Rise and Rise of Medicinal Cannabis, What Now? Medicinal Cannabis Prescribing in Australia 2017–2022," IJERPH, MDPI, vol. 19(16), pages 1-7, August.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;
    ;

    JEL classification:

    • R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
    • Z0 - Other Special Topics - - General

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:abf:journl:v:41:y:2022:i:4:p:32889-32895. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Angela Roy (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.